BioCentury
ARTICLE | Company News

ArcherDx, Enzymatics deal

September 16, 2013 7:00 AM UTC

Tool supplier Enzymatics acquired cancer-centric sequencing kit and software company ArcherDx in a deal valued up to $50 million comprised of cash, equity and milestones. ArcherDx co-founder and CEO J...